Share on StockTwits

EXACT Sciences (NASDAQ:EXAS) shares reached a new 52-week high during trading on Friday , Analyst Ratings News reports. The company traded as high as $20.49 and last traded at $20.44, with a volume of 1,743,922 shares. The stock had previously closed at $19.65.

A number of research firms have recently commented on EXAS. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of EXACT Sciences in a research note on Tuesday, August 12th. They now have a $20.00 price target on the stock, up previously from $19.00. Separately, analysts at Benchmark Co. upgraded shares of EXACT Sciences to a “buy” rating in a research note on Tuesday, August 12th. Finally, analysts at Jefferies Group raised their price target on shares of EXACT Sciences from $18.00 to $20.00 in a research note on Wednesday, July 23rd. They now have a “buy” rating on the stock. Two analysts have rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $19.50.

The stock has a 50-day moving average of $16.72 and a 200-day moving average of $14.45. The company’s market cap is $1.656 billion. EXACT Sciences also saw some unusual options trading activity on Wednesday. Traders purchased 5,569 put options on the stock. This is an increase of approximately 314% compared to the typical daily volume of 1,344 put options.

EXACT Sciences (NASDAQ:EXAS) last posted its quarterly earnings results on Tuesday, July 22nd. The company reported ($0.24) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.25) by $0.01. During the same quarter last year, the company posted ($0.19) earnings per share. Analysts expect that EXACT Sciences will post $-1.14 EPS for the current fiscal year.

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer.

Receive News & Ratings for EXACT Sciences Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EXACT Sciences Co and related companies with Analyst Ratings Network's FREE daily email newsletter.